VivaGel®, in a gel formulation for management of BV and STI prevention, is currently in clinical trials and is not available for sale in any countries.
The VivaGel® condom is currently not avaialble for purchase. The VivaGel® condom has obtained conformity assessment certification from the Australian Therapeutic Goods Administration (TGA); and regulatory certification (marketing approval) has also been granted for marketing by Okamoto of the VivaGel® condom in Japan.
It has come to the attention of Starpharma that an unrelated company called Optimally Holding Co., Ltd. is marketing a product named "VIVA balanced sterilization fluid" with the package bearing the mark "VIVAgel". The company also uses of the websites www.optimallyholding.com, www.usoptm.com and www.usviva.net.